AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.560
+0.110 (4.49%)
At close: Jun 26, 2026, 4:00 PM EDT
2.580
+0.020 (0.78%)
After-hours: Jun 26, 2026, 4:27 PM EDT
AC Immune Employees
As of December 31, 2025, AC Immune had 122 total employees, including 90 full-time and 32 part-time employees. The number of employees decreased by 50 or -29.07% compared to the previous year.
Employees
122
Change (1Y)
-50
Growth (1Y)
-29.07%
Revenue / Employee
$37,830
Profits / Employee
-$676,680
Market Cap
253.95M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Fate Therapeutics | 161 |
| Lyell Immunopharma | 161 |
| Nautilus Biotechnology | 127 |
| Invivyd | 122 |
| Niagen Bioscience | 117 |
| Foghorn Therapeutics | 106 |
| Orchestra BioMed Holdings | 86 |
| Armata Pharmaceuticals | 61 |
ACIU News
- 16 days ago - AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson's Disease - GlobeNewsWire
- 22 days ago - AC Immune Slides: Investor presentation - Filings
- 5 weeks ago - AC Immune presents new Phase 1 data on uptake of ACI-19626 - TheFly
- 5 weeks ago - AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS - GlobeNewsWire
- 6 weeks ago - Davos Alzheimer's Collaborative Celebrates Andrea Pfeifer, Retiring CEO of AC Immune, for Her Contributions to Alzheimer's Policy, Research and Care - GlobeNewsWire
- 6 weeks ago - AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM - GlobeNewsWire
- 2 months ago - AC Immune reports Q1 EPS (15c), consensus (14c) - TheFly
- 2 months ago - AC Immune First Quarter 2026 Financial and Corporate Updates - GlobeNewsWire